Most NexGard side effects in dogs are mild digestive upsets that resolve on their own within 24 to 72 hours. Because the drug’s active ingredient, afoxolaner, has a relatively long half-life of about two weeks in a dog’s body, the rare side effects that do occur can sometimes linger longer than you might expect from a single chewable tablet. Understanding what is common versus what is genuinely concerning helps you react appropriately if your dog seems off after a dose.
The Most Common Side Effects and How Quickly They Pass
The side effects dog owners encounter most often after giving NexGard are gastrointestinal: vomiting, soft stool, or diarrhea. In safety studies testing afoxolaner-based formulations at three and five times the recommended dose, the digestive issues observed were described as mild and self-resolving.1PubMed. Safety of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate in dogs For the vast majority of dogs, this means a single episode of vomiting within hours of taking the chewable, or a day or two of loose stools, followed by a return to normal. Decreased appetite and lethargy sometimes accompany these digestive symptoms but likewise tend to clear within a day or two.
If your dog vomits within the first couple of hours after swallowing the tablet, the question becomes whether enough of the drug was absorbed. Afoxolaner reaches peak blood levels roughly two to six hours after ingestion, and the chewable dissolves rapidly once swallowed.2PubMed. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs If you see most of the tablet in the vomit, your dog may not have gotten a full dose. Your vet can advise on whether to re-dose or wait.
Why the Drug Stays in the System So Long
Afoxolaner binds extremely tightly to proteins in your dog’s blood, with plasma protein binding above 99.9%.2PubMed. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs That high binding is what makes NexGard effective for a full month: the drug is slowly released from its protein reservoir rather than being quickly flushed out. The terminal half-life averages about 15.5 days, meaning it takes roughly two weeks for half the drug to be eliminated, and several more weeks before blood levels drop to negligible amounts. This is by design, since the goal is to keep enough afoxolaner circulating to kill fleas and ticks for 30 days.
The practical consequence for side effects is straightforward. If a dog does have an adverse reaction, you cannot simply “flush” the drug out. There is no antidote that neutralizes afoxolaner. Supportive care is the main tool: anti-nausea medication for vomiting, fluids for diarrhea, or anti-seizure drugs for neurological reactions. Because the drug clears gradually, a mild side effect like soft stool typically resolves well before the drug is fully eliminated, as the dog’s body adjusts. But a more serious reaction may require veterinary management over several days or, in rare cases, a couple of weeks.
Neurological Side Effects and Their Timeline
The side effects that understandably worry owners most are neurological. In 2018, the U.S. FDA issued an alert about the potential for neurological adverse events in dogs and cats treated with any drug in the isoxazoline class, which includes NexGard (afoxolaner), Bravecto (fluralaner), Simparica (sarolaner), and Credelio (lotilaner). The FDA subsequently required updated labeling across all these products to highlight the risk of tremors, ataxia (uncoordinated movement), and seizures.3PubMed Central. Survey of canine use and safety of isoxazoline parasiticides
In reported cases, muscle tremors and convulsions are the most frequently documented neurological signs.4PubMed. Neurological adverse effects of isoxazoline exposure in cats and dogs These events have been observed at normal therapeutic doses, not just overdoses. When they occur, onset can happen within hours to days of dosing. The duration is harder to pin down because published case series vary: some dogs experience a brief seizure episode that resolves within hours, while others have recurrent tremors over several days that require veterinary hospitalization. Given the drug’s long half-life, neurological signs can persist or recur until afoxolaner levels drop enough that the nervous system is no longer affected, which in some reported cases means a week or more of monitoring.
It is worth putting the risk in perspective. These neurological events are rare relative to the enormous number of doses administered globally each year. For dogs without a history of seizures or neurological disorders, the risk is extremely low, and veterinary organizations generally consider the benefits of effective flea and tick prevention to outweigh this small risk.5Parasites & Vectors. Flea, Tick, and Parasite Prevention for Dogs: What the Evidence Says in 2026 But for dogs that have already experienced seizures, the calculus shifts, and most veterinary pharmacologists recommend avoiding isoxazoline products entirely in those patients.
Which Dogs Face Higher Risk
The clearest risk factor for a neurological side effect is a pre-existing seizure disorder. If your dog has epilepsy or has had unexplained seizures, most vets will steer you toward a different class of flea and tick prevention. The AVMA and veterinary pharmacologists recommend that dogs with known seizure disorders not receive isoxazoline products.5Parasites & Vectors. Flea, Tick, and Parasite Prevention for Dogs: What the Evidence Says in 2026
A question that comes up frequently in breed-specific forums is whether dogs carrying the MDR1 gene mutation, common in collies, Australian shepherds, and some other herding breeds, are at increased risk. This mutation reduces the function of a transporter protein at the blood-brain barrier, making affected dogs more sensitive to certain drugs. However, afoxolaner has been specifically tested in homozygous MDR1-deficient collies at nearly four times the maximum recommended dose and was well tolerated, with no notable adverse effects.6PubMed Central. Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1‐deficient collie dogs This is reassuring: afoxolaner crosses cell membranes through passive diffusion rather than being actively pumped by the MDR1 transporter, so the mutation does not seem to concentrate the drug in the brain the way it does with certain other medications like ivermectin.
Very young puppies are another group owners ask about. NexGard is labeled for puppies eight weeks of age and older weighing at least four pounds. Field studies in dogs across a range of ages and sizes have not flagged age-specific side effect patterns, and safety scores in European field trials were rated “excellent” for virtually all treated dogs.7Parasites & Vectors. Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe That said, smaller dogs receive a lower absolute dose but the same concentration per kilogram, and any medication error (giving a tablet sized for a larger dog) magnifies the exposure. Double-check that you are using the correct weight range when dispensing.
Side Effects with Repeated Monthly Dosing
Since NexGard is meant to be given every month, many owners wonder whether side effects accumulate over time. A six-month field study that combined NexGard Spectra with a topical product found no adverse events related to either product over the entire study period. Clinical parameters including body temperature, heart rate, and respiratory rate stayed stable, and blood work remained within normal limits throughout.8PubMed Central. Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra® The researchers did note some statistically significant changes in certain blood values compared to baseline, but the values stayed within the normal range for dogs, which is a useful distinction: “statistically different” in a lab report does not mean “clinically worrisome” for your pet.
For most dogs, each monthly dose is handled independently. The drug from the previous month has largely cleared by the time the next dose is due, and there is no evidence of a buildup effect that worsens side effects over time. If your dog tolerated the first few doses without incident, that pattern is likely to continue.
Unusual or Rare Reactions
Beyond the common GI upsets and rare neurological events, scattered case reports document reactions that fall outside the typical profile. One published case involved a miniature dachshund that developed a serious skin condition, pemphigus foliaceus, within days of receiving NexGard. The dog had no prior history of skin disease, and the lesions worsened with each of five subsequent monthly doses before the connection was recognized.9Veterinary Record Case Reports. Probable drug‐triggered pemphigus foliaceus in a dog following administration of afoxolaner (NexGard) The dog required immunosuppressive treatment to achieve remission, and low-dose medication was needed long term to prevent relapse.
Cases like this are genuinely uncommon, and it is always difficult to prove that a drug caused a condition rather than simply coinciding with it. But the temporal pattern in the dachshund case, with lesions appearing after each dose and no prior skin problems, was suggestive enough for the veterinary team to publish it as a probable drug-triggered reaction. If your dog develops new skin lesions, persistent itching, or unexplained sores after starting NexGard, it is worth mentioning the medication to your vet even if the timing seems like it might be coincidence.
What To Do if You Suspect a Side Effect
For mild digestive symptoms, you can usually take a watch-and-wait approach. Withhold food for a few hours after vomiting, offer small amounts of water, and reintroduce a bland diet. If vomiting or diarrhea persists beyond 48 hours or your dog seems dehydrated, a vet visit is warranted. Lethargy that lasts more than a day also deserves a check-in.
Neurological signs call for immediate veterinary attention. If your dog starts trembling, seems disoriented, has trouble walking, or has a seizure after receiving NexGard, get to a vet or emergency clinic. Treatment is supportive: anti-seizure medication if needed, IV fluids, and close monitoring. Because afoxolaner cannot be removed from the body quickly, the vet’s goal is to manage symptoms while the drug level gradually declines. Most dogs that experience neurological reactions recover fully, but the timeline can stretch over days depending on severity.
You can also report suspected adverse events to the drug’s manufacturer or directly to the FDA through their online portal. These reports feed into the post-market surveillance system that led to the 2018 labeling update, so filing one contributes to the broader safety picture even if your individual dog’s case is mild.
Comparing NexGard’s Half-Life to Other Isoxazolines
Dog owners sometimes wonder whether switching to a different flea and tick product would mean faster clearance if a problem arose. The isoxazoline class includes several drugs with different dosing schedules, and those schedules reflect differences in how long each compound stays in the body. Afoxolaner in NexGard has a half-life of about two weeks and is dosed monthly. Fluralaner, the active ingredient in Bravecto, stays in the body much longer: after a single topical dose in dogs, plasma concentrations plateau for roughly eight weeks and remain detectable for more than 12 weeks.10BioMed Central / Springer Nature (Parasites & Vectors). Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration That longer persistence is why Bravecto is labeled for 12-week dosing rather than monthly.
From a side-effect-duration standpoint, a shorter half-life means the drug clears faster if a reaction occurs. This makes NexGard somewhat more forgiving than Bravecto in a hypothetical adverse scenario, though both are generally well tolerated. Sarolaner (Simparica) and lotilaner (Credelio) have their own pharmacokinetic profiles, with sarolaner’s half-life falling in a similar range to afoxolaner’s. All four products carry the same FDA class-wide neurological warning, so the risk category is consistent across the group even though the clearance times differ.
When Side Effects Are Actually Something Else
Not every symptom that follows a NexGard dose is caused by the drug. Dogs that eat a flavored chewable might also have gotten into something else that day. Garbage gut, dietary indiscretion, or a new treat introduced at the same time can produce identical GI symptoms. Seasonal changes, stress from a vet visit (where the chewable was often given), and concurrent medications can all muddy the picture.
One pattern that veterinarians occasionally see is owners attributing tick-borne illness symptoms to the preventive itself. A dog already harboring an early Lyme or ehrlichiosis infection might start showing lethargy, joint stiffness, or appetite loss around the time of a NexGard dose, leading the owner to blame the chewable. If your dog’s symptoms do not fit the typical NexGard side-effect profile, especially if they include fever, shifting lameness, or swollen lymph nodes, your vet may want to run a tick-borne disease panel before concluding the medication is the problem.
Another source of confusion is the timing of flea allergy flare-ups. NexGard kills fleas after they bite, not before. A dog with flea allergy dermatitis can still have an itchy, inflamed reaction from flea bites even while on the medication, and some owners interpret the ongoing scratching as a drug side effect. The drug is working by killing fleas that feed, which eventually breaks the flea life cycle, but the allergic response to saliva from bites already received can take days to settle down on its own.
Feeding and Timing Tips That May Reduce GI Upset
The NexGard label notes that the chewable can be given with or without food, but giving it with a meal generally improves absorption and may reduce the chance of stomach upset. Afoxolaner’s oral bioavailability is about 74%, and a fatty meal can help the drug dissolve and absorb more evenly, reducing the likelihood of a concentrated hit to an empty stomach.2PubMed. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs If your dog has vomited after a previous dose taken on an empty stomach, try tucking the chewable into a small portion of their regular food next time.
Some owners also prefer to give the dose in the morning so they can monitor their dog throughout the day. This is not a medical recommendation so much as a practical comfort: if a reaction is going to happen, it is easier to respond during waking hours. For dogs that have had no issues over multiple months of dosing, timing matters much less, and evening dosing is perfectly fine.